EDUCATION IN HEART

Valve disease

Management of infective endocarditis

Gilbert Habib

Correspondence to:
Correspondence to:
Dr Gilbert Habib
Hôpital Timone, Cardiologie B, Boulevard Jean Moulin, 13005 Marseille, France; gilbert.habib@ap-hm.fr

Keywords: infectious endocarditis

The first 150 words of the full text of this article appear below.

Infective endocarditis (IE) is a disease that is continually changing, with new high risk patients, new diagnostic procedures, the involvement of new microorganisms, and new therapeutic methods.¹ Despite knowledge of these changes, and considerable improvements in diagnostic and therapeutic strategies, IE is still a severe disease.² The high morbidity and mortality rate of IE is the consequence of both the destructive valvar lesions causing valve regurgitation and heart failure, and the valvar vegetations with their high embolic potential. Although the incidence of IE is relatively stable, those patients affected by the disease are older and sicker, and the co-morbidity rate is high.³ As soon as the diagnosis of IE is suspected, the physician is faced with four specific problems:

• First, the diagnosis of IE is still difficult and is frequently delayed, causing progressive and irreparable valvar damage.
  
• Second, IE is still associated with high in-hospital mortality, ranging from . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

WEB TOP 10
Heart 2006 92: 528. [Extract] [Full Text] [PDF]

WEB TOP 10
Heart 2006 92: 400. [Extract] [Full Text] [PDF]

MULTIPLE CHOICE QUESTIONS
Heart 2006 92: 130. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Endorsed by the European Society of Clinical Micro, , Authors/Task Force Members, , Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., Lekakis, J., Lengyel, M., Muller, L., Naber, C. K., Nihoyannopoulos, P., Moritz, A., Zamorano, J. L., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Auricchio, A., Bax, J., Ceconi, C., Dean, V., Filippatos, G., Funck-Brentano, C., Hobbs, R., Kearney, P., McDonagh, T., McGregor, K., Popescu, B. A., Reiner, Z., Sechtem, U., Sirnes, P. A., Tendera, M., Vardas, P., Widimsky, P., Document Reviewers, , Vahanian, A., Aguilar, R., Bongiorni, M. G., Borger, M., Butchart, E., Danchin, N., Delahaye, F., Erbel, R., Franzen, D., Gould, K., Hall, R., Hassager, C., Kjeldsen, K., McManus, R., Miro, J. M., Mokracek, A., Rosenhek, R., San Roman Calvar, J. A., Seferovic, P., Selton-Suty, C., Uva, M. S., Trinchero, R., van Camp, G. (2009). Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 30: 2369-2413 [Full Text]  
• Nadji, G., Rusinaru, D., Remadi, J.-P., Jeu, A., Sorel, C., Tribouilloy, C. (2009). Heart failure in left-sided native valve infective endocarditis: characteristics, prognosis, and results of surgical treatment. Eur J Heart Fail 11: 668-675 [Abstract] [Full Text]  
• Falagas, M. E., Giannopoulou, K. P., Ntziora, F., Vardakas, K. Z. (2007). Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence. J Antimicrob Chemother 60: 7-19 [Abstract] [Full Text]  
• Cecchi, E, Imazio, M, Trinchero, R (2006). The changing face of infective endocarditis.. Heart 92: 1365-1366 [Abstract] [Full Text]  
• Beynon, R. P, Bahl, V K, Prendergast, B. D (2006). Infective endocarditis. BMJ 333: 334-339 [Full Text]  
• Falagas, M. E., Manta, K. G., Ntziora, F., Vardakas, K. Z. (2006). Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence. J Antimicrob Chemother 58: 273-280 [Abstract] [Full Text]